Emerald Mutual Fund Advisers Trust Immuno Gen, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$12.46 - $29.95 $3.46 Million - $8.32 Million	-277,854 Reduced 18.95%	1,188,209 $35.2 Million
Q3 2023 Oct 26, 2023	BUY	$14.09 - $19.87 $9.15 Million - $12.9 Million	649,069 Added 79.45%	1,466,063 $23.3 Million
Q2 2023 Aug 10, 2023	BUY	$3.75 - $20.05 $3.06 Million - $16.4 Million	816,994 New	816,994 $15.4 Million

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.